Get the Stockscreener App
0.8497
1.77%
-0.0153
After Hours:
.87
0.0203
+2.39%
Estrella Immunopharma Inc stock is traded at $0.8497, with a volume of 3,515.
It is down -1.77% in the last 24 hours and down -3.43% over the past month.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
See More
Previous Close:
$0.865
Open:
$0.92
24h Volume:
3,515
Relative Volume:
0.02
Market Cap:
$30.73M
Revenue:
-
Net Income/Loss:
$-8.53M
P/E Ratio:
-3.491
EPS:
-0.2434
Net Cash Flow:
$-12.75M
1W Performance:
+1.23%
1M Performance:
-3.43%
6M Performance:
-24.81%
1Y Performance:
-40.37%
1-Day Range:
$0.8497
$0.92
1-Week Range:
$0.8172
$0.92
52-Week Range:
$0.63
$1.78
Estrella Immunopharma Inc Stock (ESLA) Company Profile
Name
Estrella Immunopharma Inc
Sector
Industry
Phone
(510) 318-9098
Address
5858 HORTON STREET, SUITE 370, EMERYVILLE
Compare ESLA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
0.8497 | 31.28M | 0 | -8.53M | -12.75M | -0.2434 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Estrella Immunopharma Inc Stock (ESLA) Latest News
Will Estrella Immunopharma Inc. benefit from macro trendsWeekly Volume Report & Community Shared Stock Ideas - Newser
What machine learning models say about Estrella Immunopharma Inc.2025 Price Momentum & Consistent Growth Stock Picks - Newser
Is Estrella Immunopharma Inc. stock bottoming outMarket Performance Report & Verified Short-Term Plans - Newser
What earnings revisions data tells us about Estrella Immunopharma Inc.July 2025 Retail & Daily Stock Trend Reports - Newser
Why Estrella Immunopharma Inc. stock attracts strong analyst attentionWeekly Profit Recap & Safe Entry Trade Reports - Newser
Analyzing recovery setups for Estrella Immunopharma Inc. investorsQuarterly Trade Report & High Conviction Investment Ideas - Newser
How Estrella Immunopharma Inc. stock performs during market volatilityMarket Risk Analysis & Short-Term Trading Alerts - Newser
Visualizing Estrella Immunopharma Inc. stock with heatmapsTreasury Yields & High Accuracy Investment Entry Signals - Newser
Is Estrella Immunopharma Inc. a defensive stock2025 Breakouts & Breakdowns & Precise Entry and Exit Recommendations - thegnnews.com
Using data tools to time your Estrella Immunopharma Inc. exitWeekly Trade Report & Safe Capital Growth Plans - Newser
What makes Estrella Immunopharma Inc. stock price move sharplySafe Momentum Strategy With Trend Analysis - Newser
Estrella Immunopharma Faces Nasdaq Non-Compliance Notice - MSN
Should you hold or exit Estrella Immunopharma Inc. nowFree AI Driven Buy Alert Trade Blueprint - Newser
How high can Estrella Immunopharma Inc. stock goLow Volatility Stock Analysis With Confidence - Newser
Will Estrella Immunopharma Inc. price bounce be sustainableAI Intraday Market Movement Prediction Tool - Newser
Is Estrella Immunopharma Inc. stock reversal real or fakeFree Weekly Hot Picks With Buy Confidence - Newser
Advanced analytics toolkit walkthrough for Estrella Immunopharma Inc.Near-Term Market Opportunity Forecast Sheet - Newser
Trend analysis for Estrella Immunopharma Inc. this weekShort-Term Support and Resistance Forecast - Newser
How to monitor Estrella Immunopharma Inc. with trend dashboardsLong-Term Safety Investment Analysis Report - Newser
Should you wait for a breakout in Estrella Immunopharma Inc.Trade Safety Report with Pattern Insights - Newser
Analyzing Estrella Immunopharma Inc. with risk reward ratio chartsCapital Secure Pattern Signal Analysis Sheet - Newser
Can Estrella Immunopharma Inc. rally from current levelsSmart Entry Watchlist with Daily Analysis - Newser
Estrella Immunopharma Inc Stock (ESLA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):